138 related articles for article (PubMed ID: 23318966)
21. Routine bone marrow biopsy has little or no therapeutic consequence for positron emission tomography/computed tomography-staged treatment-naive patients with Hodgkin lymphoma.
El-Galaly TC; d'Amore F; Mylam KJ; de Nully Brown P; Bøgsted M; Bukh A; Specht L; Loft A; Iyer V; Hjorthaug K; Nielsen AL; Christiansen I; Madsen C; Johnsen HE; Hutchings M
J Clin Oncol; 2012 Dec; 30(36):4508-14. PubMed ID: 23150698
[TBL] [Abstract][Full Text] [Related]
22. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Mahmood S; Martinez de Llano SR
Clin Nucl Med; 2008 Jul; 33(7):510-2. PubMed ID: 18580246
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact of FDG-PET/CT in the planning of radiotherapy for early-stage Hodgkin lymphoma.
Hutchings M; Loft A; Hansen M; Berthelsen AK; Specht L
Eur J Haematol; 2007 Mar; 78(3):206-12. PubMed ID: 17253974
[TBL] [Abstract][Full Text] [Related]
24. Lymphoma and tuberculosis: temporal evolution of dual pathology on sequential 18F-FDG PET/CT.
Mukherjee A; Sharma P; Karunanithi S; Dhull VS; Kumar R
Clin Nucl Med; 2014 Aug; 39(8):736-7. PubMed ID: 24566399
[TBL] [Abstract][Full Text] [Related]
25. Bone metastasis versus bone marrow metastasis? Integration of diagnosis by (18)F-fluorodeoxyglucose positron emission/computed tomography in advanced malignancy with super bone scan: two case reports and literature review.
Lin CY; Chen YW; Chang CC; Yang WC; Huang CJ; Hou MF
Kaohsiung J Med Sci; 2013 Apr; 29(4):229-33. PubMed ID: 23541269
[TBL] [Abstract][Full Text] [Related]
26. Nonossifying fibroma can mimic residual lymphoma in FDG PET: additional value of combined PET/CT.
von Falck C; Rosenthal H; Gratz KF; Galanski M
Clin Nucl Med; 2007 Aug; 32(8):640-2. PubMed ID: 17667441
[TBL] [Abstract][Full Text] [Related]
27. Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
Karantanis D; O'Neill BP; Subramaniam RM; Peller PJ; Witte RJ; Mullan BP; Wiseman GA
Clin Nucl Med; 2007 Apr; 32(4):271-4. PubMed ID: 17413571
[TBL] [Abstract][Full Text] [Related]
28. Advanced-stage Hodgkin lymphoma: US/chest radiography for detection of relapse in patients in first complete remission--a randomized trial of routine surveillance imaging procedures.
Picardi M; Pugliese N; Cirillo M; Zeppa P; Cozzolino I; Ciancia G; Pettinato G; Salvatore C; Quintarelli C; Pane F
Radiology; 2014 Jul; 272(1):262-74. PubMed ID: 24708193
[TBL] [Abstract][Full Text] [Related]
29. Non-Hodgkin's lymphoma of the bone and the liver without lymphadenopathy revealed on FDG-PET/CT.
Cheng G; Servaes S; Chamroonrat W; Li J; Zhuang H
Clin Imaging; 2010; 34(6):476-9. PubMed ID: 21092880
[TBL] [Abstract][Full Text] [Related]
30. Focused regional FDG PET/CT detects more osseous metastases than does whole-body PET/CT.
Mojtahedi A; Solomon SB; Ulaner GA
Clin Nucl Med; 2013 Mar; 38(3):217-8. PubMed ID: 23357824
[TBL] [Abstract][Full Text] [Related]
31. Assessment of tumor size reduction improves outcome prediction of positron emission tomography/computed tomography after chemotherapy in advanced-stage Hodgkin lymphoma.
Kobe C; Kuhnert G; Kahraman D; Haverkamp H; Eich HT; Franke M; Persigehl T; Klutmann S; Amthauer H; Bockisch A; Kluge R; Wolf HH; Maintz D; Fuchs M; Borchmann P; Diehl V; Drzezga A; Engert A; Dietlein M
J Clin Oncol; 2014 Jun; 32(17):1776-81. PubMed ID: 24799482
[TBL] [Abstract][Full Text] [Related]
32. Texture analysis on (18)F-FDG PET/CT images to differentiate malignant and benign bone and soft-tissue lesions.
Xu R; Kido S; Suga K; Hirano Y; Tachibana R; Muramatsu K; Chagawa K; Tanaka S
Ann Nucl Med; 2014 Nov; 28(9):926-35. PubMed ID: 25107363
[TBL] [Abstract][Full Text] [Related]
33. FDG PET/CT differentiating two malignant tumors in the same patient.
Shai A; Leitzin L; Steiner M; Peer A; Srour S; Shalom RB
Acta Oncol; 2012 Jan; 51(1):142-4. PubMed ID: 21851187
[No Abstract] [Full Text] [Related]
34. Role of 18FDG-PET/CT in detecting relapse during follow-up of patients with Hodgkin's lymphoma.
Crocchiolo R; Fallanca F; Giovacchini G; Ferreri AJ; Assanelli A; Verona C; Pescarollo A; Bregni M; Ponzoni M; Gianolli L; Fazio F; Ciceri F
Ann Hematol; 2009 Dec; 88(12):1229-36. PubMed ID: 19468730
[TBL] [Abstract][Full Text] [Related]
35. The appearance of osseous PEComa on F-18 FDG PET/CT.
Rakheja R; Abikhzer G; Alabed YZ; Nahal A; Lisbona R
Clin Nucl Med; 2012 Feb; 37(2):190-2. PubMed ID: 22228350
[TBL] [Abstract][Full Text] [Related]
36. Extranodal malignant lymphoma: detection with FDG PET versus CT.
Moog F; Bangerter M; Diederichs CG; Guhlmann A; Merkle E; Frickhofen N; Reske SN
Radiology; 1998 Feb; 206(2):475-81. PubMed ID: 9457202
[TBL] [Abstract][Full Text] [Related]
37. Autoimmune lymphoproliferative syndrome and non-Hodgkin lymphoma: what 18F-fluorodeoxyglucose positron emission tomography/computed tomography can do in the management of these patients? Suggestions from a case report.
Cistaro A; Pazè F; Durando S; Cogoni M; Faletti R; Vesco S; Vallero S; Quartuccio N; Treglia G; Ramenghi U
Rev Esp Med Nucl Imagen Mol; 2014; 33(2):99-102. PubMed ID: 23845452
[TBL] [Abstract][Full Text] [Related]
38. 18F-FDG PET/CT findings in patients with Kikuchi disease.
Kong E; Chun K; Hong Y; Hah J; Cho I
Nuklearmedizin; 2013; 52(3):101-6. PubMed ID: 23681151
[TBL] [Abstract][Full Text] [Related]
39. Contrast-enhanced harmonic compound US of the spleen to increase staging accuracy in patients with Hodgkin lymphoma: a prospective study.
Picardi M; Soricelli A; Pane F; Zeppa P; Nicolai E; De Laurentiis M; Grimaldi F; Rotoli B
Radiology; 2009 May; 251(2):574-82. PubMed ID: 19401581
[TBL] [Abstract][Full Text] [Related]
40. 18F-FDG PET/CT in a case of multifocal skeletal tuberculosis without pulmonary disease and potential role for monitoring treatment response.
Cho YS; Chung DR; Lee EJ; Kim BT; Lee KH
Clin Nucl Med; 2014 Nov; 39(11):980-3. PubMed ID: 24561689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
